Drug Testing Policy
Drug Testing Policy template for pre-employment, random, reasonable suspicion, post-accident, and DOT-regulated testing. Use it to set clear rules, protect safety, and document consequences consistently.
Trusted by frontline teams 15 years of frontline software AI customization in seconds
Built for: Transportation And Logistics · Construction · Manufacturing · Healthcare · Utilities
Overview
This Drug Testing Policy template sets out when testing is allowed, who can authorize it, how results are handled, and what happens after a refusal or positive result. It is built for employers that need a clear process for pre-employment, random, reasonable suspicion, post-accident, return-to-duty, follow-up, and DOT-regulated testing.
Use it when you need a written policy that supervisors can actually follow and employees can understand before testing occurs. The template is especially useful for safety-sensitive workplaces, regulated operations, and employers that need to coordinate testing with prescription medication disclosures, medical marijuana issues, and the ADA interactive process. It also gives you a place to define confidentiality, record retention, and non-retaliation rules so testing does not become a source of inconsistent discipline.
Do not use a one-size-fits-all version if your workforce spans multiple states or includes both DOT-covered and non-covered employees. State law may limit off-duty cannabis discipline, require specific notice, or add privacy protections, and the policy should call those carve-outs out explicitly. It is also not a substitute for supervisor training, chain-of-custody procedures, or a medical review process. If your current practice is informal or handled case by case, this template helps you convert that practice into a documented policy with clear triggers, roles, and consequences.
Standards & compliance context
- The policy should align with ADA requirements for reasonable accommodation and the interactive process when prescription medication, disability, or treatment may be involved.
- Discipline and testing triggers should be applied consistently to avoid Title VII, ADEA, and EEOC disparate treatment or disparate impact concerns.
- Reasonable suspicion and post-accident testing should be tied to documented facts and safety concerns, including OSHA general duty clause considerations where impairment creates a hazard.
- If employees engage in concerted complaints about testing practices, the policy should not interfere with NLRA Section 7 rights or protected concerted activity.
- DOT-regulated testing must follow the applicable DOT drug and alcohol testing rules for covered roles, while non-covered employees may be subject to different procedures.
- State law may add restrictions for cannabis, off-duty conduct, privacy, paid sick leave coordination, whistleblower protections, or notice requirements, so applicable_jurisdictions should be listed explicitly.
General regulatory context for orientation only — verify current requirements with counsel or the relevant agency before relying on this template for compliance.
What's inside this template
Purpose
Explains why the policy exists and what risks it is meant to control.
-
The purpose of this policy is to promote a safe, productive, and drug-free workplace by establishing clear rules for drug and alcohol testing. This policy is intended to support workplace safety, protect employees and the public, and ensure compliance with applicable federal, state, and local laws, including the Drug-Free Workplace Act of 1988, the ADA, Title VII, the FLSA, and DOT testing requirements where applicable.
Scope
Defines which workers, locations, and testing situations the policy applies to.
-
This policy applies to all employees, applicants, interns, temporary workers, and contractors where permitted by law. Additional requirements apply to employees in safety-sensitive positions and to employees subject to DOT-regulated testing. **California employees:** testing practices must be administered in a manner consistent with California law, including privacy and off-duty conduct protections where applicable. **Other state-specific overlays:** the Company will follow any stricter state or local law governing notice, consent, testing methods, marijuana-related protections, or disciplinary action.
Definitions
Clarifies terms like reasonable suspicion, refusal to test, adulteration, and safety-sensitive role.
-
For purposes of this policy, the following terms apply: - **Drug test**: A test for controlled substances or other substances prohibited by this policy. - **Alcohol test**: A test used to determine the presence or level of alcohol in an employee's system. - **Good-faith reasonable suspicion**: A belief supported by observable facts, not rumor or stereotype. - **Essential function**: A fundamental job duty of a position, as defined under the ADA. - **Interactive process**: A timely, individualized discussion to determine whether a reasonable accommodation is available for a qualified employee with a disability.
Policy Statement
States the employer's core rule on prohibited substance use and testing eligibility.
-
Employees must not report to work, remain at work, or perform Company business while impaired by alcohol, illegal drugs, or the misuse of prescription or over-the-counter medications. The Company may require drug and alcohol testing in the following circumstances, to the extent permitted by law: 1. **Pre-employment testing** for applicants who receive a conditional offer of employment. 2. **Random testing** for employees in safety-sensitive or DOT-regulated positions, or other positions where permitted by law. 3. **Reasonable suspicion testing** when trained management personnel observe signs of impairment. 4. **Post-accident testing** following a workplace accident, injury, or incident as defined by law or Company procedure. 5. **Return-to-duty or follow-up testing** when required by DOT rules, a last-chance agreement, or a documented rehabilitation plan. The Company will not use testing in a manner that unlawfully discriminates against applicants or employees, and will consider reasonable accommodation obligations under the ADA through the interactive process when appropriate.
Testing Procedures
Lays out the step-by-step process for pre-employment, random, suspicion-based, post-accident, and return-to-duty testing.
-
The Company will administer testing using a qualified laboratory, collection site, and Medical Review Officer (MRO) or equivalent review process where required. - **Pre-employment testing:** Applicants may be required to complete testing after a conditional offer and before start date. - **Random testing:** Selection will be conducted using a neutral, objective method where required by law or policy. - **Reasonable suspicion testing:** The observing supervisor or manager must document specific behaviors, appearance, speech, odor, or performance concerns and consult HR before directing testing whenever practicable. - **Post-accident testing:** Testing may be required after an accident involving injury, property damage, or safety risk, consistent with applicable law and internal incident reporting procedures. - **DOT-regulated testing:** Covered employees will be tested in accordance with applicable DOT rules, including pre-employment, random, reasonable suspicion, post-accident, return-to-duty, and follow-up testing as required. Employees must cooperate with testing requests, provide accurate identification, and remain available for collection procedures. Refusal to test, adulteration, substitution, or tampering may be treated as a policy violation.
Prescription Medications, Medical Marijuana, and Accommodation
Explains how disclosures, the ADA interactive process, and state cannabis rules are handled.
-
Employees must notify HR or the designated contact if they are using prescription or over-the-counter medication that may affect safety or their ability to perform essential functions. Employees should not disclose unrelated medical information beyond what is necessary for assessment. The Company will evaluate accommodation requests through the interactive process when a medical condition may be involved. Nothing in this policy requires the Company to permit impairment at work, excuse unsafe conduct, or waive DOT requirements. Where state law provides protections for lawful off-duty cannabis use or other substances, the Company will apply those protections to the extent required by law, while maintaining safety-sensitive and federally regulated testing obligations.
Confidentiality and Records
Sets rules for who can access results, how records are stored, and how long they are kept.
-
Testing information, results, and related medical documentation will be maintained as confidential personnel or medical records, stored separately from general personnel files to the extent required by law. Access will be limited to HR, safety, legal, management personnel with a business need to know, and external vendors involved in testing administration. The Company will handle personal data in accordance with applicable privacy laws, including state privacy requirements and, where applicable, GDPR or CCPA obligations. Test records will be retained only as long as required by law, contract, or legitimate business need.
Consequences
Describes the discipline path for positive tests, refusals, tampering, or policy violations.
-
Violations of this policy may result in corrective action up to and including removal from the hiring process, suspension, mandatory referral to an Employee Assistance Program (EAP), a documented warning, a Performance Improvement Plan (PIP), final warning, or termination of employment, depending on the circumstances and applicable law. For DOT-regulated employees, consequences will be administered in accordance with DOT rules and any required return-to-duty process. The Company may also remove an employee from duty pending investigation or test results where safety concerns exist.
Roles and Responsibilities
Assigns duties to supervisors, HR, safety, managers, and any medical review vendor.
-
**HR / Compliance:** administer the policy, coordinate vendors, maintain records, and ensure legal compliance. **Managers / Supervisors:** identify and document reasonable suspicion indicators, escalate concerns promptly, and avoid making medical diagnoses. **Employees:** comply with testing requests, report safety concerns, and disclose work-related medication issues when they may affect safe performance. **Medical Review Officer / Testing Vendor:** conduct specimen collection, review results, and report verified outcomes as required. **Policy holder:** the HR Director or designated Compliance Officer is responsible for approving exceptions, coordinating updates, and ensuring annual review.
Compliance, Discipline, and Non-Retaliation
Connects the policy to legal compliance, consistent discipline, and protection against retaliation.
-
The Company will enforce this policy in a manner consistent with the NLRA, Title VII, the ADA, FMLA, FLSA, OSHA's General Duty Clause, and applicable state law. Employees may raise concerns about safety, testing procedures, or accommodations without retaliation. Nothing in this policy prohibits protected concerted activity under Section 7 of the NLRA, lawful leave rights under the FMLA, or legally protected whistleblowing. Any discipline will be based on documented facts, applied consistently, and reviewed for legal compliance before final action.
Review and Revision
Shows when the policy is updated and who approves changes.
-
This policy will be reviewed at least annually and updated as needed to reflect changes in federal, state, and local law, DOT requirements, testing vendor practices, and Company operations. Revisions must be approved by the policy holder, HR, and legal counsel where appropriate.
How to use this template
- 1. Fill in the effective_date, version, applicable_jurisdictions, applicable_roles, and review_frequency fields before distributing the policy.
- 2. Decide which testing triggers you actually use, then remove any unused categories such as random, post-accident, or DOT-specific testing.
- 3. Assign clear roles for supervisors, HR, safety, collection sites, and medical review so no one person controls the entire process.
- 4. Add your state-specific carve-outs for cannabis, privacy, off-duty conduct, and any notice or consent requirements before rollout.
- 5. Train managers on reasonable suspicion documentation, confidentiality, and escalation so they can apply the policy consistently.
- 6. Review every positive, refusal, or accommodation request through the stated procedure and document the outcome, discipline, or interactive process step.
Best practices
- Use observable facts, not conclusions, when documenting reasonable suspicion, and record the date, time, behavior, and witnesses.
- Separate safety-sensitive and DOT-covered roles from other roles so the policy does not overreach or under-apply required testing rules.
- State exactly who may order a test and who may receive results to reduce confidentiality breaches and inconsistent approvals.
- Include a clear chain-of-custody and specimen handling process so collection errors do not undermine the result.
- Treat prescription medication disclosures through the interactive process when an ADA issue may exist, rather than applying automatic discipline.
- Spell out how medical marijuana is handled in each applicable jurisdiction, especially where state law limits off-duty use discipline.
- Use the same documented warning and discipline ladder for similar violations unless a law, safety rule, or DOT requirement requires a different response.
What this template typically catches
Issues teams running this template most often surface in practice:
Common use cases
Frequently asked questions
What types of testing does this policy cover?
This template covers pre-employment, random, reasonable suspicion, post-accident, return-to-duty, and follow-up testing, plus DOT-regulated testing where applicable. It is written to help a policy holder define when testing can occur and what happens after a positive, refused, or adulterated test. You can remove any testing type you do not use, but the policy should stay consistent with your actual practice.
Who should administer or approve drug testing under this policy?
Typically HR, a safety manager, or a designated policy holder coordinates testing, while supervisors are limited to documenting observable facts for reasonable suspicion. Medical review should be handled by a qualified medical review officer when the process requires it. The template separates decision-making, collection, and review so one person is not controlling every step.
How often should this policy be reviewed?
Review it at least annually and any time your testing program changes, your state law changes, or you add a DOT-covered role. Annual review helps keep the policy aligned with FLSA classification issues, ADA accommodation obligations, and state-specific marijuana rules. The template includes effective_date, version, applicable_jurisdictions, and review_frequency fields so updates are easy to track.
How does this policy handle prescription medications and medical marijuana?
The template includes a separate section for prescription medications, medical marijuana, and the interactive process so you can distinguish lawful use from safety-sensitive impairment concerns. It is important not to treat every positive result the same way, especially where state law protects off-duty cannabis use or requires individualized review. The policy should explain how employees disclose medication use and how the company evaluates reasonable accommodation requests under the ADA.
What legal issues does a drug testing policy need to address?
A strong policy should account for ADA reasonable accommodation, Title VII consistency, NLRA protected concerted activity, FLSA classification issues, and DOT rules where applicable. State overlays often matter too, especially for marijuana, privacy, and off-duty conduct laws. This template is designed to flag those issues without pretending that one national rule fits every jurisdiction.
What are the most common mistakes in drug testing policies?
Common mistakes include vague reasonable suspicion standards, no chain-of-custody procedure, no confidentiality language, and automatic discipline that ignores accommodation or state-law exceptions. Another frequent gap is failing to define who can order a test and what documentation is required before a post-accident or suspicion-based test. This template gives you a structure that reduces ad hoc decisions and inconsistent enforcement.
Can this template be customized for safety-sensitive or DOT-regulated roles?
Yes. The template is meant to be customized for safety-sensitive positions, DOT-covered employees, and roles where impairment creates an OSHA general duty clause risk. You can add role-specific testing triggers, supervisor training requirements, and return-to-duty steps without rewriting the whole policy. If you have both covered and non-covered employees, the policy should clearly separate the two groups.
How does this compare with an informal, case-by-case approach?
An informal approach often leads to uneven enforcement, weak documentation, and avoidable retaliation or discrimination claims. This template gives you a repeatable process for testing, review, discipline, and recordkeeping so supervisors know what to do before a situation happens. It also helps show that decisions were made in good faith and based on documented criteria rather than guesswork.
Related templates
Ready to use this template?
Get started with MangoApps and use Drug Testing Policy with your team — pricing built for small business.
